JAMA Clinical Reviews podcast

Treatment of Severe Refractory Asthma

0:00
14:39
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics.

Related Content:

-----------------------------------

JAMA Editors' Summary

Fler avsnitt från "JAMA Clinical Reviews"